Characteristic , outcome of heart failure hospitalization, mortality rate and factors associated with heart failure mortality in Kalasin Hospital, retrospective study.
Keywords:
Heart failure, hospitalization, mortalityAbstract
This study was retrospective study aimed to evaluate heart failure hospitalized patients in Kalasin Hospital in year 2021 to evaluate characteristics, risk factors, precipitating factors, heart failure management, outcome and factors associated with in-hospital mortality. Include all the heart failure hospitalized patients from 1st January until 31st December 2021. The data was retrieved by medical records. Patients’ characteristics, echocardiography, xrays, laboratorys, heart failure managements were evaluated. Mortality and rehospitalization rate in 1 year were calculated. Factors associated with in-hospital mortality were calculated by univariate and multivariate analysis.
Results : Patients factors that associated with in-hospital mortality were functional class, Killip classification, diabetes mellitus adjusted OR 5.89 95%CI 2.05-16.94,p 0.001 , gout adjusted OR 7.21(95%CI 1.64-31.6) ,p 0.009 the precipitating factors of heart failure which increased risk of in-hospital mortality were thyroid abnormalities OR 9.34(1.01-86.7) p0.05, anemia OR 51.89 95%CI 11.14-241.77 p 0.000 and NSAIDS used OR17.79 95%CI 1.26-250.90 p0.033. In patients that were safely discharge, the rate of appropriated guideline-directed medical treatment according to Thai heart failure guideline were low.
References
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. 2022 May 3 [cited 2023 Feb 24];145(18). Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063
Laothavorn P, Hengrussamee K, Kanjanavanit R, Moleerergpoom W, Laorakpongse D, Pachirat O, et al. Thai Acute Decompensated Heart Failure Registry (Thai ADHERE). Glob Heart. 2010 Sep 1;5(3):89.
Ariyachaipanich A, Krittayaphong R, Ayudhya R, Yingchoncharoen T, Buakhamsri A, Suvachittanont N. Heart failure council of Thailand (HFCT) 2019 heart failure guideline: Introduction and diagnosis. J Med Assoc Thai. 2019 Feb 1;102.
Moleerergpoom W, Hengrussamee K, Piyayotai D, Jintapakorn W, Sukhum P, Kunjara-Na-Ayudhya R, et al. Predictors of In-Hospital Mortality in Acute Decompensated Heart Failure (Thai ADHERE). 2013;96(2).
Lam CSP. Heart failure in Southeast Asia: facts and numbers. ESC Heart Fail. 2015 Jun;2(2):46–9.
HFCT Focused Update of the 2019 HFCT Heart Failure Guidelines: Part 1 - Heart Failure Classification and Pharmacological Treatment for Heart Failure with Reduced Ejection Fraction (HFrEF). J Med Assoc Thai. 2022 Nov 15;105(11):1153–9.
Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob Health. 2017 Jul;5(7):e665–72.
Kamimura D, Cain LR, Mentz RJ, White WB, Blaha MJ, DeFilippis AP, et al. Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study. Circulation. 2018 Jun 12;137(24):2572–82.
Reddy PKV, Ng TMH, Oh EE, Moady G, Elkayam U. Clinical Characteristics and Management of Methamphetamine‐Associated Cardiomyopathy: State‐of‐the‐Art Review. J Am Heart Assoc. 2020 Jun 2;9(11):e016704.
Marques I, Abreu S, Bertão MV, Ferreira B, Ramos RL, Lopes J, et al. Characteristics and outcomes of heart failure hospitalization before implementation of a heart failure clinic: The PRECIC study. Rev Port Cardiol. 2017 Jun;36(6):431–8.
Verdu-Rotellar JM, Vaillant-Roussel H, Abellana R, Jevsek LG, Assenova R, Lazic DK, et al. Precipitating factors of heart failure decompensation, short-term morbidity and mortality in patients attended in primary care. Scand J Prim Health Care. 2020 Oct 1;38(4):473–80.
Rotunno R, Oppo I, Saetta G, Aveta P, Bruno S. NSAIDs and heart failure: A dangerous relationship. Monaldi Arch Chest Dis.
Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K, et al. Acute heart failure. Nat Rev Dis Primer. 2020 Mar 5;6(1):16.
Holgado JL, Lopez C, Fernandez A, Sauri I, Uso R, Trillo JL, et al. Acute kidney injury in heart failure: a population study. ESC Heart Fail.
Rosano GM, Vitale C, Seferovic P. Heart Failure in Patients with Diabetes Mellitus. Card Fail Rev.
Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, et al. Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. DIABETES CARE. 2010;33(7).
Triposkiadis F, Xanthopoulos A, Bargiota A, Kitai T, Katsiki N, Farmakis D, et al. Diabetes Mellitus and Heart Failure. 2021;
Chen HH, Hsieh MC, Ho CW, Chen CC, Hsu SP, Chang SS, et al. Increased the risk of heart failure and comorbidities in patients with gout treatment: a population-based cohort study. Ann Transl Med. 2020;8(7).
Han Y. Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey. 2023;
Asheim A, Nilsen SM, Aam S, Anthun KS, Carlsen F, Janszky I, et al. High ward occupancy, bedspacing, and 60 day mortality for patients with myocardial infarction, stroke, and heart failure. ESC Heart Fail.
Prediction of In-Hospital Mortality for ICU Patients with Heart Failure.
Ruthirago D, Wongpraparut N, Rn SN, Nimmannit A, Udompunturak S, Pongakasira R. Checklist for Heart Failure Treatments Improves Adherence to Guideline-Directed Treatment and Outcomes in Patients with Chronic Heart Failure with Reduced Ejection Fraction. J Med Assoc Thai. 2017;100(9).
